[1]
S. Kothari, P. Patel, M. Changulani, and A. Agrawal, “Efficacy, tolerability and cost effectiveness of zotepine versus olanzapine in patients of acute schizophrenia”, Int J Basic Clin Pharmacol, vol. 2, no. 5, pp. 577–582, Feb. 2017.